サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1684437

免疫血液学の世界市場：種類別・用途別・エンドユーザー別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2025年～2032年)

Immunohematology Market, By Type, By Application, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

出版日
ページ情報
英文 301 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
免疫血液学の世界市場：種類別・用途別・エンドユーザー別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2025年～2032年)
出版日: 2025年02月04日
発行: AnalystView Market Insights
ページ情報: 英文 301 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

免疫血液学の市場規模は2024年に26億943万米ドルとなり、2025年から2032年にかけてCAGR 7.82%で拡大

免疫血液学の市場力学

免疫血液学市場は、血液疾患や慢性疾患の罹患率の増加によって牽引されています。世界保健機関（WHO）によると、貧血は世界で約16億2,000万人に影響を及ぼしています。このようなケースでは、高度な血液検査と輸血サービスの重要性が強調されます。さらに、世界の外科手術の増加は、血液製剤と免疫血液学サービスの需要に寄与しています。献血を推進する意識や政府の取り組みが血液製剤の入手可能性を高め、市場の拡大を促しています。次世代シークエンシングとポリメラーゼ連鎖反応（PCR）の導入により免疫血液学診断の精度が向上し、臨床現場での採用が増加しています。

新興市場は免疫血液学業界にとって大きな成長の可能性を秘めています。新興諸国の医療インフラへの投資は、診断と輸血サービスの向上に向けられると思われます。さらに、個別化医療や血液管理に対する患者ごとのアプローチの人気が高まっているため、免疫血液学に特化した製品やサービスが市場に活路を見出すことができます。また、献血に対する意識と安全基準を高めるための官民協力も、市場の成長を後押しすると思われます。しかし、高度な診断機器や複雑な診断機器を操作する高度な技術を持つ人材にかかるコストは高く、市場の妨げになる可能性が高いです。さらに、血液製剤や診断機器に関する規制は非常に厳しいことが多いため、製品登録や市場参入が遅れ、新しいソリューションの迅速な提供に影響を及ぼす可能性があります。

免疫血液学市場：主な考察

試薬部門は、血液型検査やクロスマッチングで非常に多く使用されているため、市場最大であり、その理由の1つは、高品質で信頼性の高い試薬に対する需要の高まりです。

病院には近代的な診断設備があり、患者管理のために複雑な免疫血液学検査を実施できる熟練したスタッフがいるため、病院は免疫血液学市場の最大セグメントです。

北米は、医療体制の整備、輸血件数の多さ、市場競争の優位性などから市場をリードしています。

アジア太平洋は、医療システムの継続的な改善、国民の献血意識、医療技術への投資促進により、最も急速に成長しています。

免疫血液学市場：セグメンテーション分析

世界の免疫血液学市場は、種類、用途、エンドユーザー、地域によって区分されます。

種類別では、免疫血液学市場は分析装置と試薬に分けられます。試薬セグメントが市場を独占しています。血液型分類、クロスマッチング、スクリーニングプロセスは試薬に依存するため、試薬が市場を独占しています。患者集団における血液疾患の発生率の増加と輸血の頻度により、血液銀行は試薬キットの精度を高めた血液銀行試薬キットに依存することが強く求められています。輸血の適合性を確保し、溶血性疾患を管理するために病院、血液銀行、診断検査室で広く使用されていることが、これらの試薬の重要性を強調しています。分析装置セグメントは予測期間中に最も急成長すると予想されます。これは、血液検査手順において、より優れた精度、迅速な納期、効率的なワークフローを提供する自動・半自動分析装置への需要が高まっているためです。検査室の自動化に対する世界の動向は、分析装置セグメントの成長を促進する最も重要な要因の一つです。

エンドユース別では、免疫血液学市場は血液バンク、病院、診断・参照検査室、学術・研究機関に分けられます。病院は免疫血液学市場の最大セグメントです。なぜなら、病院は患者のケアに不可欠であり、手術や外傷の際には血液型検査、クロスマッチング、輸血サービスが不可欠となることが多いからです。また、病院には近代的な診断施設があり、患者管理のために複雑な免疫血液学検査を実施できる熟練者がいます。予測期間中、血液バンク分野が最も高いCAGRを示すと予測されます。これは主に、人々の自発的な献血を奨励する意識の高まりと関連プログラム、それに続く血液バンクと収集センターの拡大によるものです。血液バンクは、十分な供給量を確保・維持するため、また互換性を保ちながら感染症を検出するために最新の免疫血液学を利用する必要があるため、不可避の存在となっています。特に第三世界諸国における血液バンクの開発は、安全な輸血の普及を可能にし、市場の成長をさらに後押ししています。

免疫血液学市場：地域別分析

北米市場が圧倒的な存在感を示しています。医療提供システムの高度なインフラと、年間輸血量の多さによる技術の最大活用が、この市場のシェアを説明しています。米国では、CDCの統計によると毎年平均約1,460万単位の輸血が行われており、免疫血液学に関連する製品やサービスを必要とする地域として非常に高い評価を得ています。この市場に貢献している主要国には、強固な医療システムと医療技術革新への継続的投資で知られる米国とカナダが含まれます。アジア太平洋地域は、予測期間中に最も急速な成長が見込まれます。これは、医療支出の促進、献血に関する意識の向上、血液関連疾患の増加によるものです。インドや中国のような国々は最近、医療インフラや輸血サービスを改善しており、WHOはこのような変化が増加していると観察しています。このような動向から、中国、インド、日本などの国々は、この成長市場の最前線に位置しており、免疫血液学の実践における多くの改善とともに今後も続くと思われます。

免疫血液学市場：競合情勢

世界の免疫血液学市場は競争が激しく、イノベーションを推進し、市場規模を拡大している主要企業が数社存在します。市場の主要企業には、Bio-Rad Laboratories, Inc.、Immucor、Ortho Clinical Diagnostics、Grifols、BD（Becton Dickinson）などがあり、これらの企業は広範な製品ポートフォリオと強固な販売網により市場を独占しています。これらの企業は、診断の精度と効率を高めるため、自動分析装置、試薬、分子診断薬などの高度な免疫血液学ソリューションの開発に注力しています。戦略的提携、合併、買収は、製品ラインナップを拡大し、新興市場に参入するための一般的な戦略です。企業はまた、医療機関や血液銀行と提携することで、アジア太平洋やラテンアメリカで拡大する市場を提供することができます。新世代の免疫血液学技術の開発を目指した研究開発への投資も、市場の競合情勢に拍車をかけています。このようなダイナミックな環境は、免疫血液学分野のさらなる開発を促進すると思われます。

目次

第1章 免疫血液学市場の概要

  • 調査範囲
  • 市場推定期間

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 免疫血液学の主な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 免疫血液学市場：産業分析

  • PEST分析
  • ポーターのファイブフォース分析
  • 市場成長の見通し：マッピング
  • 規制体制の分析

第5章 免疫血液学市場：高まる地政学的緊張の影響

  • COVID-19パンデミックの影響
  • ロシア・ウクライナ戦争の影響
  • 中東紛争の影響

第6章 免疫血液学の市場情勢

  • 免疫血液学の市場シェア分析 (2024年)
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 免疫血液学市場：種類別

  • 概要
    • セグメント別シェア分析：種類別
    • 分析装置
    • 試薬

第8章 免疫血液学市場：用途別

  • 概要
    • セグメント別シェア分析：用途別
    • 抗体スクリーニング
    • 血液型検査

第9章 免疫血液学市場：エンドユーザー別

  • 概要
    • セグメント別シェア分析：エンドユーザー別
    • 血液バンク
    • 病院
    • 診断・参照検査室
    • 学術研究機関

第10章 免疫血液学市場：地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • オランダ
    • スウェーデン
    • ロシア
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • インドネシア
    • タイ
    • フィリピン
    • その他
  • ラテンアメリカ（LATAM）
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東およびアフリカ（MEA）
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析：免疫血液学業界

  • 競合ダッシュボード
    • 競合ベンチマーク
    • 競合ポジショニング
  • 企業プロファイル
    • Bio-Rad Laboratories, Inc.
    • Immucor
    • Ortho Clinical Diagnostics
    • Grifols
    • BD（Becton Dickinson）
    • Hologic, Inc.
    • Siemens Healthineers
    • ThermoFisher
    • Abbott
    • Beckman Coulter, Inc.

第12章 AnalystViewの全方位的分析

目次
Product Code: ANV4745

REPORT HIGHLIGHT

Immunohematology Market size was valued at US$ 2,609.43 Million in 2024, expanding at a CAGR of 7.82% from 2025 to 2032.

Immunohematology, more often referred to as blood banking or transfusion medicine, is the area of hematology and immunology that studies antigens and antibodies related to blood. This is one of the most indispensable healthcare fields, mainly focused on the identification and compatibility of blood for transfusions, and understanding the disorders that might be associated with immune reactions in the blood. The general theme for this field refers to the detection, characterization, and clinical implications of blood group antigens and their corresponding antibodies. The immunohematology foundation lies in ABO and Rh blood group systems, which are critical for blood compatibility determination. Immunohematology tests entail cross-matching, screening irregular antibodies, and detecting antigens predisposing individuals to adverse reactions related to transfusions or pregnancy. Such includes the hemolytic disease of the fetus and the newborn. Modern medicine could hardly do without it since applying blood and other blood products guarantees the treatment of numerous diseases- from traumas and surgeries, through anemias, to chronic diseases.

Immunohematology Market- Market Dynamics

The immunohematology market is driven by increased incidence of hematological disorders and chronic diseases. According to the World Health Organization, anemia has affected around 1.62 billion people globally. Such cases emphasize the importance of advanced blood testing and transfusion services. Moreover, the increased number of surgical procedures worldwide contributes to the demand for blood products & immunohematology services. Propelling awareness and government initiatives promoting blood donation have increased the availability of blood products, thereby stimulating market expansion. Incorporating next-generation sequencing and polymerase chain reaction (PCR) has improved the accuracy of immunohematology diagnostics, encouraging increased adoption in clinical settings.

Emerging markets hold significant growth potential for the immunohematology industry. Developing countries' investment in healthcare infrastructure would be targeted towards improving diagnostics & blood transfusion services. Moreover, with the increasing popularity of personalized medicine and the patient-specific approach toward blood management, specialized immunohematology products and services can find a scope in the market. Public-private collaborations to increase blood donation awareness and safety standards will also favor market growth. However, the high costs for advanced diagnostic equipment and the highly skilled personnel operating complex diagnostic instruments will likely hinder the market. Furthermore, regulations often very stringent concerning blood products and diagnostic devices usually delay product registration and entry to the market, possibly affecting the prompt availability of new solutions.

Immunohematology Market- Key Insights

Reagents segment is the largest in the market, because of their immense usage in blood typing and cross-matching, one of the reasons being the growth in demand for quality and reliable reagents.

Hospitals are the largest segment of the immunohematology market since hospitals have modern diagnostic facilities and skilled personnel who can perform intricate immunohematology tests for patient management.

North America leads the market, based on a better-established healthcare structure, a more significant number of blood transfusion procedures, and leadership of top competition.

Asia Pacific is growing fastest due to continuous improvement in health systems, blood donation awareness among the population, and health technology investment push.

Immunohematology Market- Segmentation Analysis:

The Global Immunohematology Market is segmented on the basis of Type, Application, End User, and Region.

By type, the immunohematology market is divided into analyzers and reagents. The reagent segment dominates the market. Blood grouping, cross-matching, and the screening process depend on reagents; hence, it gains the domination power. Increased incidence of hematological disease in the patient population, together with the frequency of blood transfusions, has highly demanded that blood banks depend upon the blood banking reagent kits having increased accuracy levels in the reagent kits. Widespread usage in hospitals, blood banks, and diagnostic laboratories for ensuring compatibility in blood transfusions and managing hemolytic diseases has emphasized the importance of these reagents. The analyzers segment is expected to grow the fastest during the forecast period. This is due to the growing demand for automated & semi-automated analyzers that offer better precision, quicker turnaround times, and efficient workflow in blood testing procedures. The global trend towards automation in laboratories has been one of the most significant factors driving the growth of the analyzers segment.

By end use, the immunohematology market is divided into blood banks, hospitals, diagnostic and reference laboratories, and academic and research institutes. Hospitals are the largest segment of the immunohematology market. This is because hospitals are critical in patient care, where blood typing, cross-matching, and transfusion services are often essential during surgery and trauma. Hospitals also have modern diagnostic facilities and skilled personnel who can perform intricate immunohematology tests for patient management. The blood banks segment is projected to exhibit the highest CAGR during the forecast period. This is mainly due to heightened awareness and associated programs encouraging people to opt for voluntary donations, followed by an expansion of blood banks and collection centers. Blood banks have become unavoidable as they constitute and sustain a secured adequate supply and need to avail themselves of the latest immunohematology in their operations to detect infections while being compatible. Development in blood banks- especially in third-world countries, allows for increased penetration of safe blood transfusions, further propelling market growth.

Immunohematology Market- Geographical Insights

The North American market dominates, having a substantial presence. Advanced infrastructure of healthcare delivery systems and maximum utilization of technology with significant amounts of transfusion per annum explain the share here. The United States is claimed to transfuse an average of around 14.6 million units every year in blood as transcribed by the CDC, marking this region very highly for requiring products and services related to immunohematology. Leading nations contributing to this market include the US & Canada, known for their solid healthcare systems and continuous investment in medical innovations. The Asia-Pacific region is expected to experience the fastest growth during the forecast period. This is due to propelling healthcare expenditure, increased awareness regarding blood donation, and increased blood-related disorders. Countries such as India & China have recently improved their health infrastructure & blood transfusion services, with the WHO observing that such changes are increasing. These trends put countries like China, India, and Japan at the forefront of this growing market and are likely to continue with much improvement in the practice of immunohematology.

Immunohematology Market- Competitive Landscape:

The global immunohematology market is highly competitive, with the presence of a few key players who are driving innovation and expanding their market footprint. The leading companies in the market include Bio-Rad Laboratories, Inc., Immucor, Ortho Clinical Diagnostics, Grifols, and BD (Becton Dickinson), which have dominated the market due to their extensive product portfolios & robust distribution networks. These players focus on developing advanced immunohematology solutions, such as automated analyzers, reagents, and molecular diagnostics, to enhance diagnostic accuracy & efficiency. Strategic collaborations, mergers, and acquisitions are common strategies used to expand product offerings and penetrate emerging markets. Companies are also able to provide increasing markets in Asia-Pacific and Latin America by partnering with healthcare institutions and blood banks. Investments in research and development, aiming to develop new-generation immunohematology technologies, add to the market's competitive landscape. This dynamic environment is likely to propel further developments in the immunohematology sector.

Recent Developments:

April 2024: Grifols launched the Erytra Eflexis automated blood-typing technology in the Chinese market after approval from the appropriate authorities. It automates processes in blood typing and enhances efficiency at blood banks.

May 2023: Bio-Rad Laboratories, Inc. launched the IH-500TM NEXT System, an automated ID-Card system. The system is an improvement of blood type testing sensitivity as well as screening for antibodies.

November 2023: Versiti bought Pearl Pathways, a Indianapolis-based blood management software company. This will help Versiti improve their digital capabilities and better manage the blood supply chain.

July 2023: QuidelOrtho partners with BYG4lab to enrich its Informatics Offerings. The collaboration will focus on creating new software products for blood banks and transfusion centers.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL IMMUNOHEMATOLOGY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Bio-Rad Laboratories, Inc.
  • Immucor
  • Ortho Clinical Diagnostics
  • Grifols
  • BD (Becton Dickinson)
  • Hologic, Inc.
  • Siemens Healthineers
  • ThermoFisher
  • Abbott
  • Beckman Coulter, Inc.

GLOBAL IMMUNOHEMATOLOGY MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Analyzers
  • Reagents

GLOBAL IMMUNOHEMATOLOGY MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Antibody Screening
  • Blood Typing

GLOBAL IMMUNOHEMATOLOGY MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Blood Banks
  • Hospitals
  • Diagnostic and Reference Laboratories
  • Academic and Research Institutes

GLOBAL IMMUNOHEMATOLOGY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Immunohematology Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Immunohematology Market Snippet By Type
    • 2.1.2. Immunohematology Market Snippet by Application
    • 2.1.3. Immunohematology Market Snippet By End User
    • 2.1.4. Immunohematology Market Snippet by Country
    • 2.1.5. Immunohematology Market Snippet by Region
  • 2.2. Competitive Insights

3. Immunohematology Key Market Trends

  • 3.1. Immunohematology Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Immunohematology Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Immunohematology Market Opportunities
  • 3.4. Immunohematology Market Future Trends

4. Immunohematology Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Immunohematology Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Immunohematology Market Landscape

  • 6.1. Immunohematology Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Immunohematology Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2024 & 2032 (%)
    • 7.1.2. Analyzers
    • 7.1.3. Reagents

8. Immunohematology Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 8.1.2. Antibody Screening
    • 8.1.3. Blood Typing

9. Immunohematology Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 9.1.2. Blood Banks
    • 9.1.3. Hospitals
    • 9.1.4. Diagnostic and Reference Laboratories
    • 9.1.5. Academic and Research Institutes

10. Immunohematology Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Immunohematology Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Immunohematology Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. UK Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. Spain Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.5. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.5. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.3. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.5. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Immunohematology Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.5. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. Immunohematology Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.5.5. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. Immunohematology Key Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.6.5. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. UAE Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. UAE Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. UAE Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Immunohematology Industry

  • 11.1. Competitive Dashboard
    • 11.1.1. Competitive Benchmarking
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Bio-Rad Laboratories, Inc.
    • 11.2.2. Immucor
    • 11.2.3. Ortho Clinical Diagnostics
    • 11.2.4. Grifols
    • 11.2.5. BD (Becton Dickinson)
    • 11.2.6. Hologic, Inc.
    • 11.2.7. Siemens Healthineers
    • 11.2.8. ThermoFisher
    • 11.2.9. Abbott
    • 11.2.10. Beckman Coulter, Inc.

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us